Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/28843
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Klassen AF | - |
dc.contributor.author | Kaur M | - |
dc.contributor.author | Johnson N | - |
dc.contributor.author | Kreukels BP | - |
dc.contributor.author | McEvenue G | - |
dc.contributor.author | Morrison SD | - |
dc.contributor.author | Mullender MG | - |
dc.contributor.author | Poulsen L | - |
dc.contributor.author | Ozer M | - |
dc.contributor.author | Rowe W | - |
dc.contributor.author | Satterwhite T | - |
dc.contributor.author | Savard K | - |
dc.contributor.author | Semple J | - |
dc.contributor.author | Sørensen JA | - |
dc.contributor.author | van de Grift TC | - |
dc.contributor.author | van der Meij-Ross M | - |
dc.contributor.author | Young-Afat D | - |
dc.contributor.author | Pusic AL | - |
dc.date.accessioned | 2023-08-27T20:27:31Z | - |
dc.date.available | 2023-08-27T20:27:31Z | - |
dc.date.issued | 2018-10 | - |
dc.identifier.issn | 2044-6055 | - |
dc.identifier.issn | 2044-6055 | - |
dc.identifier.uri | http://hdl.handle.net/11375/28843 | - |
dc.description.abstract | Introduction A critical barrier to outcome assessment in gender-affirming healthcare is the lack of a specific patient-reported outcome measure (PROM). This phase I protocol describes an international collaboration between investigators in Canada, Denmark, the Netherlands and the USA who have coalesced to develop a new PROM (ie, the GENDER-Q) to evaluate outcomes of psychological, hormonal and surgical gender-affirming treatments. Methods and analysis This phase I study uses an interpretive description approach. Participants aged 16 years and older seeking any form of gender-affirming treatments in centres located in Canada, Denmark, the Netherlands and the USA will be invited to take part in qualitative interviews. Participants will review BREAST-Q and FACE-Q scales hypothesised to contain content relevant to specific gender-affirming treatments. Interviews will elicit new concepts for additional scale development. Each interview will be digitally recorded, transcribed and coded. The main outcome of this phase I study will be the development of a conceptual framework and set of scales to measure outcomes important to evaluating gender-affirming treatments. To this end, analysis will be used to add/drop/revise items of existing scales to achieve content validity. For new concepts, coding will assign top-level domains and themes/subthemes to participant quotes. Codes will be used to develop an item pool to inform scale development. Draft scales will be shown to transgender and gender diverse persons and experts to obtain feedback that will be used to refine and finalise the scales. The field-test version of the GENDER-Q will be translated by following rigorous methods to prepare for the international field-test study. Ethics and dissemination This study is coordinated at McMaster University (Canada). Ethics board approval was received from the Hamilton Integrated Ethics Board (Canada), the Medical Ethical Committee at VUmc (The Netherlands) and Advarra (USA). Findings will be published in peer-reviewed journals and presented at national and international conferences and meetings. | - |
dc.publisher | BMJ | - |
dc.subject | 4203 Health Services and Systems | - |
dc.subject | 42 Health Sciences | - |
dc.subject | Cancer | - |
dc.subject | Clinical Research | - |
dc.subject | 3 Good Health and Well Being | - |
dc.subject | Clinical Trials, Phase I as Topic | - |
dc.subject | Gender Dysphoria | - |
dc.subject | Hormone Replacement Therapy | - |
dc.subject | Humans | - |
dc.subject | Internationality | - |
dc.subject | Interviews as Topic | - |
dc.subject | Patient Reported Outcome Measures | - |
dc.subject | Psychometrics | - |
dc.subject | Quality of Life | - |
dc.subject | Transgender Persons | - |
dc.title | International phase I study protocol to develop a patient-reported outcome measure for adolescents and adults receiving gender-affirming treatments (the GENDER-Q) | - |
dc.type | Article | - |
dc.date.updated | 2023-08-27T20:27:31Z | - |
dc.contributor.department | Pediatrics | - |
dc.identifier.doi | https://doi.org/10.1136/bmjopen-2018-025435 | - |
Appears in Collections: | Pediatrics Publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
International phase I study protocol to develop a patient-reported outcome measure for adolescents and adults receiving gend.pdf | 812.56 kB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.